Milestone Scientific Inc.: Form 10-Q for the period ended Sep 30, 2014
Filed with the SEC on Nov 13, 2014 and accepted by EDGAR at Nov 13, 2014, 17:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-07-01 to 2014-09-30 | $2.5m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 9 months2014-01-01 to 2014-09-30 | $7.7m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months2014-07-01 to 2014-09-30 | $829.5k | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months2014-01-01 to 2014-09-30 | $2.6m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2014-07-01 to 2014-09-30 | $1.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2014-01-01 to 2014-09-30 | $5.0m | us-gaap:GrossProfit |
| Research and development | 3 months2014-07-01 to 2014-09-30 | $29.4k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2014-01-01 to 2014-09-30 | $74.3k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2014-07-01 to 2014-09-30 | $1.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2014-01-01 to 2014-09-30 | $4.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-07-01 to 2014-09-30 | −$162.2k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2014-01-01 to 2014-09-30 | $214.5k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2014-07-01 to 2014-09-30 | −$358.5k | us-gaap:NetIncomeLoss |
| Net income | 9 months2014-01-01 to 2014-09-30 | −$333.1k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-07-01 to 2014-09-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2014-01-01 to 2014-09-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-07-01 to 2014-09-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2014-01-01 to 2014-09-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-07-01 to 2014-09-30 | 21,189,245 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2014-01-01 to 2014-09-30 | 19,621,471 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2014-01-01 to 2014-09-30 | −$3.4k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2014-01-01 to 2014-09-30 | $66.1k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-09-30 | $781.5k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-09-30 | $15.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-09-30 | $17.3m | us-gaap:Assets |
| Current liabilities | At period end2014-09-30 | $2.0m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2014-09-30 | $15.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-14-005667. Last ingested by Listed: Nov 14, 2026, 11:14 ET. Listed shows no prices and gives no investment advice.